Literature DB >> 19244192

Accessing antiretroviral therapy following release from prison.

Jacques Baillargeon1, Thomas P Giordano, Josiah D Rich, Z Helen Wu, Katherine Wells, Brad H Pollock, David P Paar.   

Abstract

CONTEXT: Interruption of antiretroviral therapy (ART) during the first weeks after release from prison may increase risk for adverse clinical outcomes, transmission of human immunodeficiency virus (HIV), and drug-resistant HIV reservoirs in the community. The extent to which HIV-infected inmates experience ART interruption following release from prison is unknown.
OBJECTIVES: To determine the proportion of inmates who filled an ART prescription within 60 days after release from prison and to examine predictors of this outcome. DESIGN, SETTING, AND PARTICIPANTS: Retrospective cohort study of all 2115 HIV-infected inmates released from the Texas Department of Criminal Justice prison system between January 2004 and December 2007 and who were receiving ART before release. MAIN OUTCOME MEASURE: Proportion of inmates who filled an ART prescription within 10, 30, and 60 days of release from prison.
RESULTS: Among the entire study cohort (N = 2115), an initial prescription for ART was filled by 115 (5.4%) inmates within 10 days of release (95% confidence interval [CI], 4.5%-6.5%), by 375 (17.7%) within 30 days (95% CI, 16.2%-19.4%), and by 634 (30.0%) within 60 days (95% CI, 28.1%-32.0%). In a multivariate analysis of predictors (including sex, age, race/ethnicity, viral load, duration of ART, year of discharge, duration of incarceration, parole, and AIDS Drug Assistance Program application assistance), Hispanic and African American inmates were less likely to fill a prescription within 10 days (adjusted estimated risk ratio [RR], 0.4 [95% CI, 0.2-0.8] and 0.4 [95% CI, 0.3-0.7], respectively) and 30 days (adjusted estimated RR, 0.7 [95% CI, 0.5-0.9] and 0.7 [95% CI, 0.5-0.9]). Inmates with an undetectable viral load were more likely to fill a prescription within 10 days (adjusted estimated RR, 1.8 [95% CI, 1.2-2.7]), 30 days (1.5 [95% CI, 1.2-1.8]), and 60 days (1.3 [95% CI, 1.1-1.5]). Inmates released on parole were more likely to fill a prescription within 30 days (adjusted estimated RR, 1.3 [95% CI, 1.1-1.6]) and 60 days (1.5 [95% CI, 1.4-1.7]). Inmates who received assistance completing a Texas AIDS Drug Assistance Program application were more likely to fill a prescription within 10 days (adjusted estimated RR, 3.1 [95% CI, 2.0-4.9]), 30 days (1.8 [95% CI, 1.4-2.2]), and 60 days (1.3 [95% CI, 1.1-1.4]).
CONCLUSION: Only a small percentage of Texas prison inmates receiving ART while incarcerated filled an initial ART prescription within 60 days of their release.

Entities:  

Mesh:

Year:  2009        PMID: 19244192      PMCID: PMC2936238          DOI: 10.1001/jama.2009.202

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  29 in total

1.  Effect of release from prison and re-incarceration on the viral loads of HIV-infected individuals.

Authors:  Becky L Stephenson; David A Wohl; Carol E Golin; Hsiao-Chuan Tien; Paul Stewart; Andrew H Kaplan
Journal:  Public Health Rep       Date:  2005 Jan-Feb       Impact factor: 2.792

2.  Correlates of self-reported nonadherence to antiretroviral therapy in HIV-infected patients: the Swiss HIV Cohort Study.

Authors:  Tracy R Glass; Sabina De Geest; Rainer Weber; Pietro L Vernazza; Martin Rickenbach; Hansjakob Furrer; Enos Bernasconi; Matthias Cavassini; Bernard Hirschel; Manuel Battegay; Heiner C Bucher
Journal:  J Acquir Immune Defic Syndr       Date:  2006-03       Impact factor: 3.731

3.  A simple method of sample size calculation for linear and logistic regression.

Authors:  F Y Hsieh; D A Bloch; M D Larsen
Journal:  Stat Med       Date:  1998-07-30       Impact factor: 2.373

4.  Sociodemographic and psychological variables influencing adherence to antiretroviral therapy.

Authors:  V Gordillo; J del Amo; V Soriano; J González-Lahoz
Journal:  AIDS       Date:  1999-09-10       Impact factor: 4.177

5.  Interruption and discontinuation of highly active antiretroviral therapy in the multicenter AIDS cohort study.

Authors:  Xiuhong Li; Joseph B Margolick; Craig S Conover; Sheila Badri; Sharon A Riddler; Mallory D Witt; Lisa P Jacobson
Journal:  J Acquir Immune Defic Syndr       Date:  2005-03-01       Impact factor: 3.731

6.  Social stigma concerns and HIV medication adherence.

Authors:  Lance S Rintamaki; Terry C Davis; Silvia Skripkauskas; Charles L Bennett; Michael S Wolf
Journal:  AIDS Patient Care STDS       Date:  2006-05       Impact factor: 5.078

7.  Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes.

Authors:  Anita Palepu; Mark W Tyndall; Keith Chan; Evan Wood; Julio S G Montaner; Robert S Hogg
Journal:  Antivir Ther       Date:  2004-10

8.  Patients referred to an urban HIV clinic frequently fail to establish care: factors predicting failure.

Authors:  Thomas P Giordano; Fehmida Visnegarwala; A Clinton White; Catherine L Troisi; Ralph F Frankowski; Christine M Hartman; Richard M Grimes
Journal:  AIDS Care       Date:  2005-08

9.  Efficacy of a brief case management intervention to link recently diagnosed HIV-infected persons to care.

Authors:  Lytt I Gardner; Lisa R Metsch; Pamela Anderson-Mahoney; Anita M Loughlin; Carlos del Rio; Steffanie Strathdee; Stephanie L Sansom; Harvey A Siegal; Alan E Greenberg; Scott D Holmberg
Journal:  AIDS       Date:  2005-03-04       Impact factor: 4.177

10.  Public health implications of antiretroviral therapy and HIV drug resistance.

Authors:  M A Wainberg; G Friedland
Journal:  JAMA       Date:  1998-06-24       Impact factor: 56.272

View more
  160 in total

1.  Diversity of release patterns for jail detainees: implications for public health interventions.

Authors:  Anne C Spaulding; Sebastian D Perez; Ryan M Seals; Madhura A Hallman; Ravi Kavasery; Paul S Weiss
Journal:  Am J Public Health       Date:  2011-10-28       Impact factor: 9.308

2.  Directly observed versus self-administered antiretroviral therapies: preference of HIV-positive jailed inmates in San Francisco.

Authors:  Parya Saberi; Nikolai H Caswell; Ross Jamison; Milton Estes; Jacqueline P Tulsky
Journal:  J Urban Health       Date:  2012-10       Impact factor: 3.671

3.  Prevalence of chronic medical conditions among inmates in the Texas prison system.

Authors:  Amy J Harzke; Jacques G Baillargeon; Sandi L Pruitt; John S Pulvino; David P Paar; Michael F Kelley
Journal:  J Urban Health       Date:  2010-05       Impact factor: 3.671

4.  Predictors of reincarceration and disease progression among released HIV-infected inmates.

Authors:  Jacques Baillargeon; Thomas P Giordano; Amy Jo Harzke; Anne C Spaulding; Z Helen Wu; James J Grady; Gwen Baillargeon; David P Paar
Journal:  AIDS Patient Care STDS       Date:  2010-06       Impact factor: 5.078

5.  Antiretroviral Adherence Following Prison Release in a Randomized Trial of the imPACT Intervention to Maintain Suppression of HIV Viremia.

Authors:  Bethany L DiPrete; Brian W Pence; Carol E Golin; Kevin Knight; Patrick M Flynn; Jessica Carda-Auten; Jennifer S Groves; Kimberly A Powers; Becky L White; Sonia Napravnik; David A Wohl
Journal:  AIDS Behav       Date:  2019-09

6.  Optimization of human immunodeficiency virus treatment during incarceration: viral suppression at the prison gate.

Authors:  Jaimie P Meyer; Javier Cepeda; Johnny Wu; Robert L Trestman; Frederick L Altice; Sandra A Springer
Journal:  JAMA Intern Med       Date:  2014-05       Impact factor: 21.873

7.  Alcohol use disorders and antiretroviral therapy among prisoners in Argentina.

Authors:  Michael Alpert; Jeffrey A Wickersham; Mariana Vázquez; Frederick L Altice
Journal:  Int J Prison Health       Date:  2013

8.  Increased hospital and emergency department utilization by individuals with recent criminal justice involvement: results of a national survey.

Authors:  Joseph W Frank; Jeffrey A Linder; William C Becker; David A Fiellin; Emily A Wang
Journal:  J Gen Intern Med       Date:  2014-05-10       Impact factor: 5.128

9.  "Seek, test, treat and retain" for hepatitis C in the United States criminal justice system.

Authors:  Sarah Larney; Curt G Beckwith; Nickolas D Zaller; Brian T Montague; Josiah Rich
Journal:  Int J Prison Health       Date:  2014

10.  Factors linked to transitions in adherence to antiretroviral therapy among HIV-infected illicit drug users in a Canadian setting.

Authors:  Brenden Joseph; Thomas Kerr; Cathy M Puskas; Julio Montaner; Evan Wood; M-J Milloy
Journal:  AIDS Care       Date:  2015-04-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.